Cadonilimab Plus Nab -Paclitaxel for Patients With Recurrent, or Metastatic Cervical Cancer Resistant to Immune Checkpoint Inhibitors
Conditions
- Uterine Cervical Neoplasms
- Cancer of Cervix
- Cervical Cancer
- Cervical Neoplasms
- Uterine Cervical Cancer
- Cancer of the Uterine Cervix
Interventions
- DRUG: Cadonilimab
- DRUG: Nab paclitaxel
Sponsor
Women's Hospital School Of Medicine Zhejiang University
Collaborators